Predicting response to neoadjuvant chemotherapy in breast cancer
Abstract - 429 PDF - 100Abstract
A team of Malaysian researchers has found that neoadjuvant chemotherapy is a reasonable treatment option for localized (hormones negative and HER2 positive) breast cancer and further demonstrating its utility in downstaging primary breast tumor, according to a study published in the recent issue of the journal Advances in Modern Oncology Research (AMOR).
Full Text:
PDFDOI: http://dx.doi.org/10.18282/amor.v3.is1.217
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.